Cargando…
Transcriptome analysis reveals that Müllerian inhibiting substance regulates signaling pathways that contribute to endometrial carcinogenesis
Müllerian inhibiting substance (MIS) has been shown to inhibit growth of a number of tumors in vitro and/or in vivo, but the downstream pathways which it regulates are not fully understood. In the present study we show that MIS type II receptor was highly expressed in AN3CA cells, a cell line derive...
Autores principales: | Chung, Youn Jee, Kim, Hyun Jung, Park, Sang Ho, Yoon, Joo Hee, Kim, Mee Ran, Nam, Suk Woo, MacLaughlin, David T., Donahoe, Patricia K., Kim, Jang Heub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903890/ https://www.ncbi.nlm.nih.gov/pubmed/25760378 http://dx.doi.org/10.3892/ijo.2015.2920 |
Ejemplares similares
-
Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumors
por: Kim, Jang Heub, et al.
Publicado: (2014) -
The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor in myoma and adenomyosis
por: Kim, Shin Young, et al.
Publicado: (2018) -
Functional profiles of Müllerian inhibiting substance/anti-Müllerian hormone (MIS/AMH) in primarily cultured endometrial cancer cells
por: Kim, Sang Il, et al.
Publicado: (2021) -
Effect of mistletoe on endometrial stromal cell survival and vascular endothelial growth factor expression in patients with endometriosis
por: Moon, Jeong Min, et al.
Publicado: (2018) -
Towards international standardization of immunoassays for Müllerian inhibiting substance/anti-Müllerian hormone
por: Ferguson, Jackie MC, et al.
Publicado: (2018)